// App-Quantinova.ai

BSH19‐EP‐043 : Is monitoring of Low Risk MGUS Low Risk? An audit of MGUS monitoring following discharge to primary care

Researchers

Presenter

  • L. Kamuriwo

Principal Investigators

  • L.Y. Chan

  • S. Hassan

Medical Centers

  • Department of Rheumatology, Barking, Havering and Redbridge University Hospitals NHS Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Monoclonal gammopathy

  • Acute renal failure

  • Multiple Myeloma

  • AL Amyloidosis

  • Hypercalcaemia

  • Amyloid disease

Biomarkers

  • Cluster of differentiation 79A

  • Immunoglobulin G

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved